From direct to indirect lithium targets: A comprehensive review of omics data

Metallomics

Volumn 9, Issue 10, 2017, Pages 1326-1351

  Roux, Magali ^a   Dosseto, Anthony ^b  

^a BioData Consulting   (France)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; INDUSTRIAL WASTES; METAL IONS; METALS; NEURODEGENERATIVE DISEASES; PHOSPHOLIPIDS; PROTEINS;

ALZHEIMER'S DISEASE; CAUSAL RELATIONSHIPS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL ISSUES; MITOCHONDRIAL FUNCTION; MITOCHONDRIAL RESPIRATORY CHAIN; PROSTAGLANDIN SYNTHESIS; TISSUE DIFFERENTIATION;

LITHIUM;

INOSITOL; LITHIUM; MAGNESIUM; PROTEIN KINASE; PROTEOME; LITHIUM DERIVATIVE; TRANSCRIPTOME;

ALLOSTERISM; ALZHEIMER DISEASE; APOPTOSIS; BLOOD CELL; BONE DEVELOPMENT; BRAIN TISSUE; CELL DIFFERENTIATION; COGNITIVE DEFECT; EMBRYO DEVELOPMENT; ENVIRONMENTAL EXPOSURE; HUMAN; INDUCED PLURIPOTENT STEM CELL; LIPID TRANSPORT; METABOLOMICS; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OMICS; OXIDATIVE STRESS; PHENOTYPE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEOMICS; REVIEW; TISSUE DIFFERENTIATION; TRANSCRIPTOMICS; DEGENERATIVE DISEASE; DRUG EFFECTS; GENETICS; METABOLISM; METABOLOME; PATHOLOGY;

HUMANS; LITHIUM COMPOUNDS; METABOLOME; NEURODEGENERATIVE DISEASES; PROTEOME; TRANSCRIPTOME;

EID: 85031815517     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c7mt00203c     Document Type: Review

References (284)

1. A. R. Joyce B. O. Palsson The model organism as a system: integrating 'omics' data sets Nat. Rev. Mol. Cell Biol. 2006 7 198 210
2. M. H. Wake What is "Integrative Biology? Integr. Comp. Biol. 2003 43 239 241
3. D. Delneri F. L. Brancia S. G. Oliver Towards a truly integrative biology through the functional genomics of yeast Curr. Opin. Biotechnol. 2001 12 87 91
4. J. Arino E. Aydar S. Drulhe D. Ganser J. Jorrin M. Kahm F. Krause S. Petrezselyova L. Yenush O. Zimmermannova G. P. van Heusden M. Kschischo J. Ludwig C. Palmer J. Ramos H. Sychrova Systems biology of monovalent cation homeostasis in yeast: the translucent contribution Adv. Microb. Physiol. 2014 64 1 63
5. I. Bertini G. Cavallaro Metals in the "omics" world: copper homeostasis and cytochrome c oxidase assembly in a new light JBIC, J. Biol. Inorg. Chem. 2008 13 3 14
6. S. Said G. T. Hernandez Environmental exposures, socioeconomics, disparities, and the kidneys Adv. Chronic Kidney Dis. 2015 22 39 45
7. C. G. Vogiatzis G. A. Zachariadis Tandem mass spectrometry in metallomics and the involving role of ICP-MS detection: a review Anal. Chim. Acta 2014 819 1 14
8. R. Williams Chemical selection of elements by cells Coord. Chem. Rev. 2001 216 583 595
9. K. J. Waldron J. C. Rutherford D. Ford N. J. Robinson Metalloproteins and metal sensing Nature 2009 460 823 830
10. C. Andreini I. Bertini G. Cavallaro G. L. Holliday J. M. Thornton Metal ions in biological catalysis: from enzyme databases to general principles JBIC, J. Biol. Inorg. Chem. 2008 13 1205 1218
11. I. Brown What factors determine cation coordination numbers? Acta Crystallogr., Sect. B: Struct. Sci. 1988 44 545 553
12. P. Vestergaard R. W. Licht 50 Years with lithium treatment in affective disorders: present problems and priorities World J. Biol. Psychiatry 2001 2 18 26
13. P. Grof Sixty years of lithium responders Neuropsychobiology 2010 62 8 16
14. T. A. Ketter S. Miller B. Dell'Osso P. W. Wang Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium J. Affective Disord. 2016 191 256 273
15. C. A. Lazzara Y. H. Kim Potential application of lithium in Parkinson's and other neurodegenerative diseases Front. Neurosci. 2015 9 403
16. G. Agam Current hypotheses of lithium's mechanism of action as a neuropsychiatric medication ACS Chem. Neurosci. 2014 5 410
17. R. Roskoski, Jr. Src protein-tyrosine kinase structure and regulation Biochem. Biophys. Res. Commun. 2004 324 1155 1164
18. K. Oruganty N. Kannan Design principles underpinning the regulatory diversity of protein kinases Philos. Trans. R. Soc. London, Ser. B 2012 367 2529 2539
19. N. Kannan A. F. Neuwald Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha Protein Sci. 2004 13 2059 2077
20. S. S. Taylor E. Radzio-Andzelm Three protein kinase structures define a common motif Structure 1994 2 345 355
21. P. Saylor C. Wang T. J. Hirai J. A. Adams A second magnesium ion is critical for ATP binding in the kinase domain of the oncoprotein v-Fps Biochemistry 1998 37 12624 12630
22. G. Sun R. J. Budde Expression, purification, and initial characterization of human Yes protein tyrosine kinase from a bacterial expression system Arch. Biochem. Biophys. 1997 345 135 142
23. G. Sun R. J. Budde Requirement for an additional divalent metal cation to activate protein tyrosine kinases Biochemistry 1997 36 2139 2146
24. R. J. Budde L. Ramdas S. Ke Recombinant pp60c-src from baculovirus-infected insect cells: purification and characterization Prep. Biochem. 1993 23 493 515
25. Q. M. Wang P. R. Srinivas M. L. Harrison R. L. Geahlen Partial purification and characterization of the lck protein-tyrosine kinase from bovine thymus Biochem. J. 1991 279 pt 2 567 574
26. J. G. Koland R. A. Cerione Activation of the EGF receptor tyrosine kinase by divalent metal ions: comparison of holoreceptor and isolated kinase domain properties Biochim. Biophys. Acta 1990 1052 489 498
27. M. F. White H. U. Haring M. Kasuga C. R. Kahn Kinetic properties and sites of autophosphorylation of the partially purified insulin receptor from hepatoma cells J. Biol. Chem. 1984 259 255 264
28. J. Ma G. Y. Zhang Y. Liu J. Z. Yan Z. B. Hao Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia Neurosci. Res. 2004 49 357 362
29. S. Y. Park H. K. Avraham S. Avraham RAFTK/Pyk2 activation is mediated by trans-acting autophosphorylation in a Src-independent manner J. Biol. Chem. 2004 279 33315 33322
30. O. Prange T. P. Wong K. Gerrow Y. T. Wang A. El-Husseini A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin Proc. Natl. Acad. Sci. U. S. A. 2004 101 13915 13920
31. J. Ma G. Y. Zhang Lithium reduced N -methyl-d-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia Neurosci. Lett. 2003 348 185 189
32. J. A. Bertrand S. Thieffine A. Vulpetti C. Cristiani B. Valsasina S. Knapp H. M. Kalisz M. Flocco Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors J. Mol. Biol. 2003 333 393 407
33. E. ter Haar J. T. Coll D. A. Austen H. M. Hsiao L. Swenson J. Jain Structure of GSK3beta reveals a primed phosphorylation mechanism Nat. Struct. Biol. 2001 8 593 596
34. S. Y. Lu Y. J. Jiang J. W. Zou T. X. Wu Dissection of the difference between the group I metal ions in inhibiting GSK3beta: a computational study Phys. Chem. Chem. Phys. 2011 13 7014 7023
35. F. W. Herberg M. L. Doyle S. Cox S. S. Taylor Dissection of the nucleotide and metal-phosphate binding sites in cAMP-dependent protein kinase Biochemistry 1999 38 6352 6360
36. P. S. Klein D. A. Melton A molecular mechanism for the effect of lithium on development Proc. Natl. Acad. Sci. U. S. A. 1996 93 8455 8459
37. W. J. Ryves R. Dajani L. Pearl A. J. Harwood Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites Biochem. Biophys. Res. Commun. 2002 290 967 972
38. W. J. Ryves A. J. Harwood Lithium inhibits glycogen synthase kinase-3 by competition for magnesium Biochem. Biophys. Res. Commun. 2001 280 720 725
39. R. S. Jope Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes Trends Pharmacol. Sci. 2003 24 441 443
40. E. Beurel S. F. Grieco R. S. Jope Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases Pharmacol. Ther. 2015 148 114 131
41. C. Sutherland What Are the bona fide GSK3 Substrates? Int. J. Alzheimer's Dis. 2011 2011 505607
42. M. Medina F. Wandosell Deconstructing GSK-3: The Fine Regulation of Its Activity Int. J. Alzheimer's Dis. 2011 2011 479249
43. P. H. Sugden S. J. Fuller S. C. Weiss A. Clerk Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis Br. J. Pharmacol. 2008 153 suppl 1 S137 S153
44. R. S. Jope C. J. Yuskaitis E. Beurel Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics Neurochem. Res. 2007 32 577 595
45. J. D. York J. W. Ponder P. W. Majerus Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure Proc. Natl. Acad. Sci. U. S. A. 1995 92 5149 5153
46. S. Patel L. Yenush P. L. Rodriguez R. Serrano T. L. Blundell Crystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3′-phosphoadenosine-5′-phosphate phosphatase activities: a novel target of lithium therapy J. Mol. Biol. 2002 315 677 685
47. A. Dutta S. Bhattacharyya D. Dutta A. K. Das Structural elucidation of the binding site and mode of inhibition of Li(+) and Mg(2+) in inositol monophosphatase FEBS J. 2014 281 5309 5324
48. Z. Li K. A. Stieglitz A. L. Shrout Y. Wei R. M. Weis B. Stec M. F. Roberts Mobile loop mutations in an archaeal inositol monophosphatase: modulating three-metal ion assisted catalysis and lithium inhibition Protein Sci. 2010 19 309 318
49. R. Gill F. Mohammed R. Badyal L. Coates P. Erskine D. Thompson J. Cooper M. Gore S. Wood High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy Acta Crystallogr., Sect. D: Biol. Crystallogr. 2005 61 545 555
50. A. J. Ganzhorn M. C. Chanal Kinetic studies with myo-inositol monophosphatase from bovine brain Biochemistry 1990 29 6065 6071
51. A. P. Leech G. R. Baker J. K. Shute M. A. Cohen D. Gani Chemical and kinetic mechanism of the inositol monophosphatase reaction and its inhibition by Li+ Eur. J. Biochem. 1993 212 693 704
52. J. A. Bitran H. K. Manji W. Z. Potter F. Gusovsky Down-regulation of PKC alpha by lithium in vitro Psychopharmacol. Bull. 1995 31 449 452
53. H. K. Manji R. H. Lenox Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C Synapse 1994 16 11 28
54. G. Shaltiel E. C. Dalton R. H. Belmaker A. J. Harwood G. Agam Specificity of mood stabilizer action on neuronal growth cones Bipolar Disord. 2007 9 281 289
55. S. Sarkar R. A. Floto Z. Berger S. Imarisio A. Cordenier M. Pasco L. J. Cook D. C. Rubinsztein Lithium induces autophagy by inhibiting inositol monophosphatase J. Cell Biol. 2005 170 1101 1111
56. S. Patel M. Martinez-Ripoll T. L. Blundell A. Albert Structural enzymology of Li(+)-sensitive/Mg(2+)-dependent phosphatases J. Mol. Biol. 2002 320 1087 1094
57. K. A. Johnson L. Chen H. Yang M. F. Roberts B. Stec Crystal structure and catalytic mechanism of the MJ0109 gene product: a bifunctional enzyme with inositol monophosphatase and fructose 1,6-bisphosphatase activities Biochemistry 2001 40 618 630
58. J. P. Frederick A. T. Tafari S. M. Wu L. C. Megosh S. T. Chiou R. P. Irving J. D. York A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation Proc. Natl. Acad. Sci. U. S. A. 2008 105 11605 11612
59. L. Yenush J. M. Belles J. M. Lopez-Coronado R. Gil-Mascarell R. Serrano P. L. Rodriguez A novel target of lithium therapy FEBS Lett. 2000 467 321 325
60. J. M. Lopez-Coronado J. M. Belles F. Lesage R. Serrano P. L. Rodriguez A novel mammalian lithium-sensitive enzyme with a dual enzymatic activity, 3′-phosphoadenosine 5′-phosphate phosphatase and inositol-polyphosphate 1-phosphatase J. Biol. Chem. 1999 274 16034 16039
61. S. R. Nahorski C. I. Ragan R. A. Challiss Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences Trends Pharmacol. Sci. 1991 12 297 303
62. J. R. Murguia J. M. Belles R. Serrano A salt-sensitive 3′(2′),5′-bisphosphate nucleotidase involved in sulfate activation Science 1995 267 232 234
63. B. D. Spiegelberg J. Dela Cruz T. H. Law J. D. York Alteration of lithium pharmacology through manipulation of phosphoadenosine phosphate metabolism J. Biol. Chem. 2005 280 5400 5405
64. J. Zhang I. Biswas 3′-Phosphoadenosine-5′-phosphate phosphatase activity is required for superoxide stress tolerance in Streptococcus mutans J. Bacteriol. 2009 191 4330 4340
65. R. Zhang V. Villeret W. N. Lipscomb H. J. Fromm Kinetics and mechanisms of activation and inhibition of porcine liver fructose-1,6-bisphosphatase by monovalent cations Biochemistry 1996 35 3038 3043
66. V. Villeret S. Huang H. J. Fromm W. N. Lipscomb Crystallographic evidence for the action of potassium, thallium, and lithium ions on fructose-1,6-bisphosphatase Proc. Natl. Acad. Sci. U. S. A. 1995 92 8916 8920
67. P. D. van Poelje S. C. Potter M. D. Erion Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes Handb. Exp. Pharmacol. 2011 279 301 10.1007/978-3-642-17214-4-12
68. P. D. van Poelje Q. Dang M. D. Erion Discovery of fructose-1,6-bisphosphatase inhibitors for the treatment of type 2 diabetes Curr. Opin. Drug Discovery Dev. 2007 10 430 437
69. C. V. Calkin D. M. Gardner T. Ransom M. Alda The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders Ann. Med. 2013 45 171 181
70. J. W. Newcomer Medical risk in patients with bipolar disorder and schizophrenia J. Clin. Psychiatry 2006 67 e16
71. T. K. Hevor Some aspects of carbohydrate metabolism in the brain Biochimie 1994 76 111 120
72. S. B. Bhattacharya A. G. Datta Is brain a gluconeogenic organ? Mol. Cell. Biochem. 1993 125 51 57
73. O. V. Forlenza A. M. Coutinho I. Aprahamian S. Prando L. L. Mendes B. S. Diniz W. F. Gattaz C. A. Buchpiguel Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [(1)(8)F]FDG-PET study ACS Chem. Neurosci. 2014 5 484 489
74. J. Bockaert J. P. Pin Molecular tinkering of G protein-coupled receptors: an evolutionary success EMBO J. 1999 18 1723 1729
75. R. J. Lefkowitz G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization J. Biol. Chem. 1998 273 18677 18680
76. C. R. McCudden M. D. Hains R. J. Kimple D. P. Siderovski F. S. Willard G-protein signaling: back to the future Cell. Mol. Life Sci. 2005 62 551 577
77. T. M. Cabrera-Vera J. Vanhauwe T. O. Thomas M. Medkova A. Preininger M. R. Mazzoni H. E. Hamm Insights into G protein structure, function, and regulation Endocr. Rev. 2003 24 765 781
78. L. Birnbaumer A. R. Zurita On the roles of Mg in the activation of G proteins J. Recept. Signal Transduction Res. 2010 30 372 375
79. A. G. Gilman G proteins: transducers of receptor-generated signals Annu. Rev. Biochem. 1987 56 615 649
80. C. S. Malarkey G. Wang M. A. Ballicora D. E. Mota de Freitas Evidence for two distinct Mg2+ binding sites in G(s alpha) and G(i alpha1) proteins Biochem. Biophys. Res. Commun. 2008 372 866 869
81. C. Srinivasan J. Toon L. Amari A. M. Abukhdeir H. Hamm C. F. Geraldes Y. K. Ho D. Mota de Freitas Competition between lithium and magnesium ions for the G-protein transducin in the guanosine 5′-diphosphate bound conformation J. Inorg. Biochem. 2004 98 691 701
82. S. Avissar G. Schreiber A. Danon R. H. Belmaker Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex Nature 1988 331 440 442
83. G. Zimmermann D. Zhou R. Taussig Mutations uncover a role for two magnesium ions in the catalytic mechanism of adenylyl cyclase J. Biol. Chem. 1998 273 19650 19655
84. J. H. Hurley Structure, mechanism, and regulation of mammalian adenylyl cyclase J. Biol. Chem. 1999 274 7599 7602
85. H. Goldberg P. Clayman K. Skorecki Mechanism of Li inhibition of vasopressin-sensitive adenylate cyclase in cultured renal epithelial cells Am. J. Physiol. 1988 255 F995 1002
86. A. Mork A. Geisler Mode of action of lithium on the catalytic unit of adenylate cyclase from rat brain Pharmacol. Toxicol. 1987 60 241 248
87. L. Mann E. Heldman Y. Bersudsky S. F. Vatner Y. Ishikawa O. Almog R. H. Belmaker G. Agam Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect Bipolar Disord. 2009 11 885 896
88. L. Mann E. Heldman G. Shaltiel R. H. Belmaker G. Agam Lithium preferentially inhibits adenylyl cyclase V and VII isoforms Int. J. Neuropsychopharmacol. 2008 11 533 539
89. G. S. Shackelford C. A. Regni L. J. Beamer Evolutionary trace analysis of the alpha-d-phosphohexomutase superfamily Protein Sci. 2004 13 2130 2138
90. G. I. Rhyu W. J. Ray, Jr. J. L. Markley Multinuclear magnetic resonance studies of metal ion binding sites of phosphoglucomutase Biochemistry 1985 24 2536 2541
91. W. J. Ray, Jr. J. W. Long The thermodynamic and structural differences among the catalytically active complexes of phosphoglucomutase: metal ion effects Biochemistry 1976 15 4018 4025
92. L. H. Stickland The activation of phosphoglucomutase by metal ions Biochem. J. 1949 44 190 197
93. G. I. Rhyu W. J. Ray, Jr. J. L. Markley Enzyme-bound intermediates in the conversion of glucose 1-phosphate to glucose 6-phosphate by phosphoglucomutase. Phosphorus NMR studies Biochemistry 1984 23 252 260
94. W. J. Ray, Jr. E. S. Szymanki L. Ng The binding of lithium and of anionic metabolites to phosphoglucomutase Biochim. Biophys. Acta 1978 522 434 442
95. C. A. Masuda M. A. Xavier K. A. Mattos A. Galina M. Montero-Lomeli Phosphoglucomutase is an in vivo lithium target in yeast J. Biol. Chem. 2001 276 37794 37801
96. P. Csutora A. Strassz F. Boldizsar P. Nemeth K. Sipos D. P. Aiello D. M. Bedwell A. Miseta Inhibition of phosphoglucomutase activity by lithium alters cellular calcium homeostasis and signaling in Saccharomyces cerevisiae Am. J. Physiol.: Cell Physiol. 2005 289 C58 67
97. T. Nagy D. Frank E. Katai R. K. Yahiro V. S. Poor G. Montsko Z. Zrinyi G. L. Kovacs A. Miseta Lithium induces ER stress and N -glycan modification in galactose-grown Jurkat cells PLoS One 2013 8 e70410
98. G. Feier S. S. Valvassori R. B. Varela W. R. Resende D. V. Bavaresco M. O. Morais G. Scaini M. L. Andersen E. L. Streck J. Quevedo Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine Pharmacol., Biochem. Behav. 2013 103 589 596
99. S. S. Valvassori G. T. Rezin C. L. Ferreira M. Moretti C. L. Goncalves M. R. Cardoso E. L. Streck F. Kapczinski J. Quevedo Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine J. Psychiatr. Res. 2010 44 903 909
100. G. T. Rezin C. B. Furlanetto G. Scaini S. S. Valvassori C. L. Goncalves G. K. Ferreira I. C. Jeremias W. R. Resende M. R. Cardoso R. B. Varela J. Quevedo E. L. Streck Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania Mol. Neurobiol. 2014 49 877 892
101. J. S. Lai C. Zhao J. J. Warsh P. P. Li Cytoprotection by lithium and valproate varies between cell types and cellular stresses Eur. J. Pharmacol. 2006 539 18 26
102. K. R. Vinothkumar J. Zhu J. Hirst Architecture of mammalian respiratory complex I Nature 2014 515 80 84
103. J. Hirst Mitochondrial complex I Annu. Rev. Biochem. 2013 82 551 575
104. J. A. Gondal W. M. Anderson The molecular morphology of bovine heart mitochondrial NADH-ubiquinone reductase. Native disulfide-linked subunits and rotenone-induced conformational changes J. Biol. Chem. 1985 260 12690 12694
105. P. E. Lindahl K. E. Oberg Mechanism of the physiological action of rotenone Nature 1960 187 784
106. R. F. Stephens W. Guan B. S. Zhorov J. D. Spafford Selectivity filters and cysteine-rich extracellular loops in voltage-gated sodium, calcium, and NALCN channels Front. Physiol. 2015 6 153
107. T. Dudev C. Lim Ion selectivity strategies of sodium channel selectivity filters Acc. Chem. Res. 2014 47 3580 3587
108. A. Keramidas A. J. Moorhouse P. R. Schofield P. H. Barry Ligand-gated ion channels: mechanisms underlying ion selectivity Prog. Biophys. Mol. Biol. 2004 86 161 204
109. S. H. Heinemann H. Terlau W. Stuhmer K. Imoto S. Numa Calcium channel characteristics conferred on the sodium channel by single mutations Nature 1992 356 441 443
110. P. Garg A. Gardner V. Garg M. C. Sanguinetti Structural basis of ion permeation gating in Slo2.1 K + channels J. Gen. Physiol. 2013 142 523 542
111. L. K. Kaczmarek Slack, Slick and Sodium-Activated Potassium Channels ISRN Neurosci. 2013 2013 10.1155/2013/354262
112. S. Franceschetti T. Lavazza G. Curia P. Aracri F. Panzica G. Sancini G. Avanzini J. Magistretti Na+-activated K+ current contributes to postexcitatory hyperpolarization in neocortical intrinsically bursting neurons J. Neurophysiol. 2003 89 2101 2111
113. X. Liu L. Stan Leung Sodium-activated potassium conductance participates in the depolarizing afterpotential following a single action potential in rat hippocampal CA1 pyramidal cells Brain Res. 2004 1023 185 192
114. C. Butler-Munro E. J. Coddington C. H. Shirley P. M. Heyward Lithium modulates cortical excitability in vitro Brain Res. 2010 1352 50 60
115. A. Bhattacharjee C. A. von Hehn X. Mei L. K. Kaczmarek Localization of the Na+-activated K+ channel Slick in the rat central nervous system J. Comp. Neurol. 2005 484 80 92
116. C. Gebhardt S. G. Cull-Candy Lithium acts as a potentiator of AMPAR currents in hippocampal CA1 cells by selectively increasing channel open probability J. Physiol. 2010 588 3933 3941
117. N. B. Karkanias R. L. Papke Subtype-specific effects of lithium on glutamate receptor function J. Neurophysiol. 1999 81 1506 1512
118. N. B. Karkanias R. L. Papke Lithium modulates desensitization of the glutamate receptor subtype gluR3 in Xenopus oocytes Neurosci. Lett. 1999 277 153 156
119. S. F. Traynelis L. P. Wollmuth C. J. McBain F. S. Menniti K. M. Vance K. K. Ogden K. B. Hansen H. Yuan S. J. Myers R. Dingledine Glutamate receptor ion channels: structure, regulation, and function Pharmacol. Rev. 2010 62 405 496
120. R. Hashimoto C. Hough T. Nakazawa T. Yamamoto D. M. Chuang Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation J. Neurochem. 2002 80 589 597
121. S. Nonaka C. J. Hough D. M. Chuang Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N -methyl-d-aspartate receptor-mediated calcium influx Proc. Natl. Acad. Sci. U. S. A. 1998 95 2642 2647
122. O. Ghribi M. M. Herman N. K. Spaulding J. Savory Lithium inhibits aluminum-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation J. Neurochem. 2002 82 137 145
123. G. Chen G. Rajkowska F. Du N. Seraji-Bozorgzad H. K. Manji Enhancement of hippocampal neurogenesis by lithium J. Neurochem. 2000 75 1729 1734
124. H. K. Manji G. J. Moore G. Chen Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness J. Clin. Psychiatry 2000 61 suppl 9 82 96
125. H. K. Manji G. J. Moore G. Chen Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol. Psychiatry 1999 46 929 940
126. R. W. Chen D. M. Chuang Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity J. Biol. Chem. 1999 274 6039 6042
127. G. Chen W. Z. Zeng P. X. Yuan L. D. Huang Y. M. Jiang Z. H. Zhao H. K. Manji The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS J. Neurochem. 1999 72 879 882
128. S. Kendrick H. J. Kang M. P. Alam M. M. Madathil P. Agrawal V. Gokhale D. Yang S. M. Hecht L. H. Hurley The dynamic character of the BCL2 promoter i-motif provides a mechanism for modulation of gene expression by compounds that bind selectively to the alternative DNA hairpin structure J. Am. Chem. Soc. 2014 136 4161 4171
129. M. A. Glucksmann-Kuis X. Dai P. Markiewicz L. B. Rothman-Denes E. coli SSB activates N4 virion RNA polymerase promoters by stabilizing a DNA hairpin required for promoter recognition Cell 1996 84 147 154
130. H. J. Kang S. Kendrick S. M. Hecht L. H. Hurley The transcriptional complex between the BCL2 i-motif and hnRNP LL is a molecular switch for control of gene expression that can be modulated by small molecules J. Am. Chem. Soc. 2014 136 4172 4185
131. Y. Cui D. Koirala H. Kang S. Dhakal P. Yangyuoru L. H. Hurley H. Mao Molecular population dynamics of DNA structures in a bcl-2 promoter sequence is regulated by small molecules and the transcription factor hnRNP LL Nucleic Acids Res. 2014 42 5755 5764
132. S. E. Kim I.-B. Lee C. Hyeon S.-C. Hong Destabilization of i-Motif by Submolar Concentrations of a Monovalent Cation J. Phys. Chem. B 2014 118 4753 4760
133. L. Wang X. Liu R. H. Lenox Transcriptional down-regulation of MARCKS gene expression in immortalized hippocampal cells by lithium J. Neurochem. 2001 79 816 825
134. R. K. McNamara P. A. Vasquez A. A. Mathe R. H. Lenox Differential expression and regulation of myristoylated alanine-rich C kinase substrate (MARCKS) in the hippocampus of C57/BL6J and DBA/2J mice J. Neurochem. 2003 85 462 468
135. L. Wang X. Liu R. H. Lenox Transcriptional regulation of mouse MARCKS promoter in immortalized hippocampal cells Biochem. Biophys. Res. Commun. 2002 292 969 979
136. G. Periz D. Dharia S. H. Miller L. R. Keller Flagellar elongation and gene expression in Chlamydomonas reinhardtii Eukaryotic Cell 2007 6 1411 1420
137. R. H. Lenox L. Wang Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks Mol. Psychiatry 2003 8 135 144
138. N. Ozaki D. M. Chuang Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain J. Neurochem. 1997 69 2336 2344
139. M. T. Unlap R. S. Jope Lithium attenuates nerve growth factor-induced activation of AP-1 DNA binding activity in PC12 cells Neuropsychopharmacology 1997 17 12 17
140. M. B. Williams R. S. Jope Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium Psychopharmacology 1995 122 363 368
141. T. Tamura S. Morinobu Y. Okamoto A. Kagaya S. Yamawaki The effects of antidepressant drug treatments on activator protein-1 binding activity in the rat brain Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2002 26 375 381
142. M. A. Schumacher R. H. Goodman R. G. Brennan The structure of a CREB bZIP.somatostatin CRE complex reveals the basis for selective dimerization and divalent cation-enhanced DNA binding J. Biol. Chem. 2000 275 35242 35247
143. A. Heinrich A. S. von der Heyde U. Boer T. Phu do M. Tzvetkov E. Oetjen Lithium enhances CRTC oligomer formation and the interaction between the CREB coactivators CRTC and CBP-implications for CREB-dependent gene transcription Cell. Signalling 2013 25 113 125
144. U. Boer J. Eglins D. Krause S. Schnell C. Schofl W. Knepel Enhancement by lithium of cAMP-induced CRE/CREB-directed gene transcription conferred by TORC on the CREB basic leucine zipper domain Biochem. J. 2007 408 69 77
145. A. Heinrich U. Boer M. Tzvetkov E. Oetjen W. Knepel Stimulation by lithium of the interaction between the transcription factor CREB and its co-activator TORC Biosci. Rep. 2009 29 77 87
146. T. Yoshimura Y. Kawano N. Arimura S. Kawabata A. Kikuchi K. Kaibuchi GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity Cell 2005 120 137 149
147. E. M. Hur F. Q. Zhou GSK3 signalling in neural development Nat. Rev. Neurosci. 2010 11 539 551
148. C. Bro B. Regenberg G. Lagniel J. Labarre M. Montero-Lomeli J. Nielsen Transcriptional, proteomic, and metabolic responses to lithium in galactose-grown yeast cells J. Biol. Chem. 2003 278 32141 32149
149. A. Squassina M. Manchia J. Borg D. Congiu M. Costa M. Georgitsi C. Chillotti R. Ardau K. Mitropoulos G. Severino M. Del Zompo G. P. Patrinos Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder Pharmacogenomics 2011 12 1559 1569
150. R. H. Perlis J. W. Smoller M. A. Ferreira A. McQuillin N. Bass J. Lawrence G. S. Sachs V. Nimgaonkar E. M. Scolnick H. Gurling P. Sklar S. Purcell A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder Am. J. Psychiatry 2009 166 718 725
151. Y. Ding D. Ploper E. A. Sosa G. Colozza Y. Moriyama M. D. Benitez K. Zhang D. Merkurjev E. M. De Robertis Spemann organizer transcriptome induction by early beta-catenin, Wnt, Nodal, and Siamois signals in Xenopus laevis Proc. Natl. Acad. Sci. U. S. A. 2017 114 E3081 E3090
152. E. H. Davidson J. P. Rast P. Oliveri A. Ransick C. Calestani C. H. Yuh T. Minokawa G. Amore V. Hinman C. Arenas-Mena O. Otim C. T. Brown C. B. Livi P. Y. Lee R. Revilla A. G. Rust Z. Pan M. J. Schilstra P. J. Clarke M. I. Arnone L. Rowen R. A. Cameron D. R. McClay L. Hood H. Bolouri A genomic regulatory network for development Science 2002 295 1669 1678
153. E. H. Davidson J. P. Rast P. Oliveri A. Ransick C. Calestani C. H. Yuh T. Minokawa G. Amore V. Hinman C. Arenas-Mena O. Otim C. T. Brown C. B. Livi P. Y. Lee R. Revilla M. J. Schilstra P. J. Clarke A. G. Rust Z. Pan M. I. Arnone L. Rowen R. A. Cameron D. R. McClay L. Hood H. Bolouri A provisional regulatory gene network for specification of endomesoderm in the sea urchin embryo Dev. Biol. 2002 246 162 190
154. A. J. Poustka A. Kuhn D. Groth V. Weise S. Yaguchi R. D. Burke R. Herwig H. Lehrach G. Panopoulou A global view of gene expression in lithium and zinc treated sea urchin embryos: new components of gene regulatory networks Genome Biol. 2007 8 R85
155. E. Rottinger P. Dahlin M. Q. Martindale A framework for the establishment of a cnidarian gene regulatory network for "endomesoderm" specification: the inputs of ss-catenin/TCF signaling PLoS Genet. 2012 8 e1003164
156. J. C. Croce D. R. McClay The canonical Wnt pathway in embryonic axis polarity Semin. Cell Dev. Biol. 2006 17 168 174
157. M. Dominici K. Le Blanc I. Mueller I. Slaper-Cortenbach F. Marini D. Krause R. Deans A. Keating D. Prockop E. Horwitz Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 2006 8 315 317
158. M. F. Pittenger A. M. Mackay S. C. Beck R. K. Jaiswal R. Douglas J. D. Mosca M. A. Moorman D. W. Simonetti S. Craig D. R. Marshak Multilineage potential of adult human mesenchymal stem cells Science 1999 284 143 147
159. Z. Yu L. Fan J. Li Z. Ge X. Dang K. Wang Lithium chloride attenuates the abnormal osteogenic/adipogenic differentiation of bone marrow-derived mesenchymal stem cells obtained from rats with steroid-related osteonecrosis by activating the beta-catenin pathway Int. J. Mol. Med. 2015 36 1264 1272
160. P. Clement-Lacroix M. Ai F. Morvan S. Roman-Roman B. Vayssiere C. Belleville K. Estrera M. L. Warman R. Baron G. Rawadi Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice Proc. Natl. Acad. Sci. U. S. A. 2005 102 17406 17411
161. N. K. Satija D. Sharma F. Afrin R. P. Tripathi G. Gangenahalli High throughput transcriptome profiling of lithium stimulated human mesenchymal stem cells reveals priming towards osteoblastic lineage PLoS One 2013 8 e55769
162. H. Kubo M. Shimizu Y. Taya T. Kawamoto M. Michida E. Kaneko A. Igarashi M. Nishimura K. Segoshi Y. Shimazu K. Tsuji T. Aoba Y. Kato Identification of mesenchymal stem cell (MSC)-transcription factors by microarray and knockdown analyses, and signature molecule-marked MSC in bone marrow by immunohistochemistry Genes Cells 2009 14 407 424
163. Z. Yu L. Fan J. Li Z. Ge X. Dang K. Wang Lithium prevents rat steroid-related osteonecrosis of the femoral head by beta-catenin activation Endocrine 2016 52 380 390
164. Y. Yang Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis Birth Defects Res., Part C 2003 69 305 317
165. T. Akiyama Wnt/beta-catenin signaling Cytokine Growth Factor Rev. 2000 11 273 282
166. J. S. da Silva C. G. Dotti Breaking the neuronal sphere: regulation of the actin cytoskeleton in neuritogenesis Nat. Rev. Neurosci. 2002 3 694 704
167. J. A. Quiroz R. Machado-Vieira C. A. Zarate, Jr. H. K. Manji Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects Neuropsychobiology 2010 62 50 60
168. J. Italia R. Mukhopadhyaya M. S. Rajadhyaksha Differential display RT-PCR reveals genes associated with lithium-induced neuritogenesis in SK-N-MC cells Cell. Mol. Neurobiol. 2011 31 1021 1026
169. R. Nciri M. A. Boujbiha S. Jbahi M. S. Allagui A. Elfeki C. Vincent F. Croute Cytoskeleton involvement in lithium-induced SH-SY5Y neuritogenesis and the role of glycogen synthase kinase 3beta Aging: Clin. Exp. Res. 2015 27 255 263
170. R. S. Schmid R. D. Graff M. D. Schaller S. Chen M. Schachner J. J. Hemperly P. F. Maness NCAM stimulates the Ras-MAPK pathway and CREB phosphorylation in neuronal cells J. Neurobiol. 1999 38 542 558
171. M. C. Mendoza E. E. Er J. Blenis The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation Trends Biochem. Sci. 2011 36 320 328
172. V. Waetzig Y. Zhao T. Herdegen The bright side of JNKs-Multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration Prog. Neurobiol. 2006 80 84 97
173. J. Xiao Y. Liu Differential roles of ERK and JNK in early and late stages of neuritogenesis: a study in a novel PC12 model system J. Neurochem. 2003 86 1516 1523
174. P. Yuan G. Chen H. K. Manji Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo J. Neurochem. 1999 73 2299 2309
175. E. Altermann T. R. Klaenhammer PathwayVoyager: pathway mapping using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database BMC Genomics 2005 6 60
176. S. Zhong K. F. Storch O. Lipan M. C. Kao C. J. Weitz W. H. Wong GoSurfer: a graphical interactive tool for comparative analysis of large gene sets in Gene Ontology space Appl. Bioinf. 2004 3 261 264
177. S. Watanabe J. Iga A. Nishi S. Numata M. Kinoshita K. Kikuchi M. Nakataki T. Ohmori Microarray analysis of global gene expression in leukocytes following lithium treatment Hum. Psychopharmacol. 2014 29 190 198
178. H. Sugawara K. Iwamoto M. Bundo M. Ishiwata J. Ueda C. Kakiuchi J. Ishigooka T. Kato Effect of mood stabilizers on gene expression in lymphoblastoid cells J. Neural Transm. 2010 117 155 164
179. M. Costa A. Squassina I. S. Piras C. Pisanu D. Congiu P. Niola A. Angius C. Chillotti R. Ardau G. Severino E. Stochino A. Deidda A. M. Persico M. Alda M. Del Zompo Preliminary Transcriptome Analysis in Lymphoblasts from Cluster Headache and Bipolar Disorder Patients Implicates Dysregulation of Circadian and Serotonergic Genes J. Mol. Neurosci. 2015 56 688 695
180. R. C. McEachin H. Chen M. A. Sartor S. F. Saccone B. J. Keller A. R. Prossin J. D. Cavalcoli M. G. McInnis A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder BMC Syst. Biol. 2010 4 158
181. A. Squassina M. Costa D. Congiu M. Manchia A. Angius V. Deiana R. Ardau C. Chillotti G. Severino S. Calza M. Del Zompo Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients Pharmacol. Res. 2013 73 1 7
182. X. Sun L. T. Young J. F. Wang P. Grof G. Turecki G. A. Rouleau M. Alda Identification of lithium-regulated genes in cultured lymphoblasts of lithium responsive subjects with bipolar disorder Neuropsychopharmacology 2004 29 799 804
183. K. L. Carter E. Cahir-McFarland E. Kieff Epstein-barr virus-induced changes in B-lymphocyte gene expression J. Virol. 2002 76 10427 10436
184. U. Zimber-Strobl L. J. Strobl EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes Semin. Cancer Biol. 2001 11 423 434
185. M. M. Franca A. A. Jorge L. R. Carvalho E. F. Costalonga A. P. Otto F. A. Correa B. B. Mendonca I. J. Arnhold Relatively high frequency of non-synonymous GLI2 variants in patients with congenital hypopituitarism without holoprosencephaly Clin. Endocrinol. 2013 78 551 557
186. T. M. Baye T. Abebe R. A. Wilke Genotype-environment interactions and their translational implications Per. Med. 2011 8 59 70
187. B. Rollins M. V. Martin L. Morgan M. P. Vawter Analysis of whole genome biomarker expression in blood and brain Am. J. Med. Genet., Part B 2010 153b 919 936
188. A. Warburton A. L. Savage P. Myers D. Peeney V. J. Bubb J. P. Quinn Molecular signatures of mood stabilisers highlight the role of the transcription factor REST/NRSF J. Affective Disord. 2015 172 63 73
189. R. Nciri E. Bourogaa S. Jbahi M. S. Allagui A. Elfeki C. Vincent F. Croute Chronic neuroprotective effects of low concentration lithium on SH-SY5Y cells: possible involvement of stress proteins and gene expression Neural Regener. Res. 2014 9 735 740
190. Z. Yu C. Ono H. B. Kim H. Komatsu Y. Tanabe N. Sakae K. I. Nakayama H. Matsuoka I. Sora W. E. Bunney H. Tomita Four mood stabilizers commonly induce FEZ1 expression in human astrocytes Bipolar Disord. 2011 13 486 499
191. K. E. Plant E. Anderson N. Simecek R. Brown S. Forster J. Spinks N. Toms G. G. Gibson J. Lyon N. Plant The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1 Toxicol. Appl. Pharmacol. 2009 235 124 134
192. R. S. Seelan A. Khalyfa J. Lakshmanan M. F. Casanova R. N. Parthasarathy Deciphering the lithium transcriptome: microarray profiling of lithium-modulated gene expression in human neuronal cells Neuroscience 2008 151 1184 1197
193. K. Takahashi S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 2006 126 663 676
194. J. Mertens Q. W. Wang Y. Kim D. X. Yu S. Pham B. Yang Y. Zheng K. E. Diffenderfer J. Zhang S. Soltani T. Eames S. T. Schafer L. Boyer M. C. Marchetto J. I. Nurnberger J. R. Calabrese K. J. Odegaard M. J. McCarthy P. P. Zandi M. Alda C. M. Nievergelt S. Pharmacogenomics of Bipolar Disorder S. Mi K. J. Brennand J. R. Kelsoe F. H. Gage J. Yao Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder Nature 2015 527 95 99
195. X. Sun J. F. Wang M. Tseng L. T. Young Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder J. Neuropsychiatry Neurosci. 2006 31 189 196
196. R. S. Lee M. Pirooznia J. Guintivano M. Ly E. R. Ewald K. L. Tamashiro T. D. Gould T. H. Moran J. B. Potash Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene Transl. Psychiatry 2015 5 e600
197. S. H. Fatemi T. J. Reutiman T. D. Folsom The role of lithium in modulation of brain genes: relevance for aetiology and treatment of bipolar disorder Biochem. Soc. Trans. 2009 37 1090 1095
198. A. Chetcuti L. J. Adams P. B. Mitchell P. R. Schofield Microarray gene expression profiling of mouse brain mRNA in a model of lithium treatment Psychiatr. Genet. 2008 18 64 72
199. A. McQuillin M. Rizig H. M. Gurling A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder Pharmacogenet. Genomics 2007 17 605 617
200. F. Bosetti R. Seemann J. M. Bell R. Zahorchak E. Friedman S. I. Rapoport P. Manickam Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration Brain Res. Bull. 2002 57 205 209
201. J. Bousleiman A. Pinsky S. Ki A. Su I. Morozova S. Kalachikov A. Wiqas R. Silver M. Sever R. N. Austin Function of Metallothionein-3 in Neuronal Cells: Do Metal Ions Alter Expression Levels of MT3? Int. J. Mol. Sci. 2017 18 10.3390/ijms18061133
202. D. A. Lauffenburger Cell signaling pathways as control modules: complexity for simplicity? Proc. Natl. Acad. Sci. U. S. A. 2000 97 5031 5033
203. U. S. Bhalla R. Iyengar Emergent properties of networks of biological signaling pathways Science 1999 283 381 387
204. A. Kolodkin E. Simeonidis R. Balling H. V. Westerhoff Understanding complexity in neurodegenerative diseases: in silico reconstruction of emergence Front. Physiol. 2012 3 291
205. M. Kanehisa S. Goto S. Kawashima Y. Okuno M. Hattori The KEGG resource for deciphering the genome Nucleic Acids Res. 2004 32 D277 D280
206. S. Elmore Apoptosis: a review of programmed cell death Toxicol. Pathol. 2007 35 495 516
207. E. Beurel R. S. Jope The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways Prog. Neurobiol. 2006 79 173 189
208. D. M. Chuang The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials Ann. N. Y. Acad. Sci. 2005 1053 195 204
209. Y. Lan X. Liu R. Zhang K. Wang Y. Wang Z. C. Hua Lithium enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells BioMetals 2013 26 241 254
210. L. Song T. Zhou R. S. Jope Lithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptor BMC Neurosci. 2004 5 20
211. W. V. Zhang M. Jullig A. R. Connolly N. S. Stott Early gene response in lithium chloride induced apoptosis Apoptosis 2005 10 75 90
212. J. Saras P. Franzen P. Aspenstrom U. Hellman L. J. Gonez C. H. Heldin A novel GTPase-activating protein for Rho interacts with a PDZ domain of the protein-tyrosine phosphatase PTPL1 J. Biol. Chem. 1997 272 24333 24338
213. P. E. Brandish M. Su D. J. Holder P. Hodor J. Szumiloski R. R. Kleinhanz J. E. Forbes M. E. McWhorter S. J. Duenwald M. L. Parrish S. Na Y. Liu R. L. Phillips J. J. Renger S. Sankaranarayanan A. J. Simon E. M. Scolnick Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex Neuron 2005 45 861 872
214. L. Toker Y. Bersudsky I. Plaschkes V. Chalifa-Caspi G. T. Berry R. Buccafusca D. Moechars R. H. Belmaker G. Agam Inositol-related gene knockouts mimic lithium's effect on mitochondrial function Neuropsychopharmacology 2014 39 319 328
215. C. Stork P. F. Renshaw Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research Mol. Psychiatry 2005 10 900 919
216. A. Nassar A. N. Azab Effects of lithium on inflammation ACS Chem. Neurosci. 2014 5 451 458
217. S. Ghosh M. S. Hayden New regulators of NF-kappaB in inflammation Nat. Rev. Immunol. 2008 8 837 848
218. E. Beurel R. S. Jope Differential regulation of STAT family members by glycogen synthase kinase-3 J. Biol. Chem. 2008 283 21934 21944
219. P. Viatour M. P. Merville V. Bours A. Chariot Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation Trends Biochem. Sci. 2005 30 43 52
220. Z. Yu C. Ono S. Aiba Y. Kikuchi I. Sora H. Matsuoka H. Tomita Therapeutic concentration of lithium stimulates complement C3 production in dendritic cells and microglia via GSK-3 inhibition Glia 2015 63 257 270
221. R. Kuruto-Niwa M. Nakamura K. Takeishi R. Nozawa Transcriptional regulation by C/EBP alpha and -beta in the expression of the gene for the MRP14 myeloid calcium binding protein Cell Struct. Funct. 1998 23 109 118
222. E. Lagasse R. G. Clerc Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation Mol. Cell. Biol. 1988 8 2402 2410
223. S. E. Ross N. Hemati K. A. Longo C. N. Bennett P. C. Lucas R. L. Erickson O. A. MacDougald Inhibition of Adipogenesis by Wnt Signaling Science 2000 289 950 953
224. S. E. Ross R. L. Erickson N. Hemati O. A. MacDougald Glycogen Synthase Kinase 3 Is an Insulin-Regulated C/EBPα Kinase Mol. Cell. Biol. 1999 19 8433 8441
225. I. Kondratiuk S. Leski M. Urbanska P. Biecek H. Devijver B. Lechat F. Van Leuven L. Kaczmarek T. Jaworski GSK-3beta and MMP-9 Cooperate in the Control of Dendritic Spine Morphology Mol. Neurobiol. 2017 54 200 211
226. S. Kim N. Bong O. S. Kim J. Jin D. E. Kim D. K. Lee Lithium chloride suppresses LPS-mediated matrix metalloproteinase-9 expression in macrophages through phosphorylation of GSK-3beta Cell Biol. Int. 2015 39 177 184
227. L. K. Tsai Y. Leng Z. Wang P. Leeds D. M. Chuang The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanisms Neuropsychopharmacology 2010 35 2225 2237
228. D. P. Vik P. Amiguet G. J. Moffat M. Fey F. Amiguet-Barras R. A. Wetsel B. F. Tack Structural features of the human C3 gene: intron/exon organization, transcriptional start site, and promoter region sequence Biochemistry 1991 30 1080 1085
229. O. V. Forlenza V. J. De-Paula B. S. Diniz Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders ACS Chem. Neurosci. 2014 5 443 450
230. D. Blum S. Torch N. Lambeng M. Nissou A. L. Benabid R. Sadoul J. M. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog. Neurobiol. 2001 65 135 172
231. R. Farah R. Khamisy-Farah T. Amit M. B. Youdim Z. Arraf Lithium's gene expression profile, relevance to neuroprotection A cDNA microarray study Cell. Mol. Neurobiol. 2013 33 411 420
232. R. M. Youngs M. S. Chu E. G. Meloni A. Naydenov W. A. Carlezon, Jr. C. Konradi Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences J. Neurosci. 2006 26 6031 6039
233. E. M. Yazlovitskaya E. Edwards D. Thotala A. Fu K. L. Osusky W. O. Whetsell, Jr. B. Boone E. T. Shinohara D. E. Hallahan Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation Cancer Res. 2006 66 11179 11186
234. K. Watase J. R. Gatchel Y. Sun E. Emamian R. Atkinson R. Richman H. Mizusawa H. T. Orr C. Shaw H. Y. Zoghbi Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model PLoS Med. 2007 4 e182
235. E. Tsaltas T. Kyriazi C. Poulopoulou D. Kontis A. Maillis Enhancing effects of lithium on memory are not by-products of learning or attentional deficits Behav. Brain Res. 2007 180 241 245
236. A. Inokuchi R. Yamamoto F. Morita S. Takumi H. Matsusaki H. Ishibashi N. Tominaga K. Arizono Effects of lithium on growth, maturation, reproduction and gene expression in the nematode Caenorhabditis elegans J. Appl. Toxicol. 2015 35 999 1006
237. M. Consortium L. Shi L. H. Reid W. D. Jones R. Shippy J. A. Warrington S. C. Baker P. J. Collins F. de Longueville E. S. Kawasaki K. Y. Lee Y. Luo Y. A. Sun J. C. Willey R. A. Setterquist G. M. Fischer W. Tong Y. P. Dragan D. J. Dix F. W. Frueh F. M. Goodsaid D. Herman R. V. Jensen C. D. Johnson E. K. Lobenhofer R. K. Puri U. Schrf J. Thierry-Mieg C. Wang M. Wilson P. K. Wolber L. Zhang S. Amur W. Bao C. C. Barbacioru A. B. Lucas V. Bertholet C. Boysen B. Bromley D. Brown A. Brunner R. Canales X. M. Cao T. A. Cebula J. J. Chen J. Cheng T. M. Chu E. Chudin J. Corson J. C. Corton L. J. Croner C. Davies T. S. Davison G. Delenstarr X. Deng D. Dorris A. C. Eklund X. H. Fan H. Fang S. Fulmer-Smentek J. C. Fuscoe K. Gallagher W. Ge L. Guo X. Guo J. Hager P. K. Haje J. Han T. Han H. C. Harbottle S. C. Harris E. Hatchwell C. A. Hauser S. Hester H. Hong P. Hurban S. A. Jackson H. Ji C. R. Knight W. P. Kuo J. E. LeClerc S. Levy Q. Z. Li C. Liu Y. Liu M. J. Lombardi Y. Ma S. R. Magnuson B. Maqsodi T. McDaniel N. Mei O. Myklebost B. Ning N. Novoradovskaya M. S. Orr T. W. Osborn A. Papallo T. A. Patterson R. G. Perkins E. H. Peters R. Peterson K. L. Philips P. S. Pine L. Pusztai F. Qian H. Ren M. Rosen B. A. Rosenzweig R. R. Samaha M. Schena G. P. Schroth S. Shchegrova D. D. Smith F. Staedtler Z. Su H. Sun Z. Szallasi Z. Tezak D. Thierry-Mieg K. L. Thompson I. Tikhonova Y. Turpaz B. Vallanat C. Van S. J. Walker S. J. Wang Y. Wang R. Wolfinger A. Wong J. Wu C. Xiao Q. Xie J. Xu W. Yang L. Zhang S. Zhong Y. Zong W. Slikker, Jr. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements Nat. Biotechnol. 2006 24 1151 1161
238. S. Draghici P. Khatri A. C. Eklund Z. Szallasi Reliability and reproducibility issues in DNA microarray measurements Trends Genet. 2006 22 101 109
239. S. P. Gygi Y. Rochon B. R. Franza R. Aebersold Correlation between protein and mRNA abundance in yeast Mol. Cell. Biol. 1999 19 1720 1730
240. A. J. Thompson R. Williamson E. Schofield J. Stephenson D. Hanger B. Anderton Quantitation of glycogen synthase kinase-3 sensitive proteins in neuronal membrane rafts Proteomics 2009 9 3022 3035
241. B. T. D. Tobe A. M. Crain A. M. Winquist B. Calabrese H. Makihara W. N. Zhao J. Lalonde H. Nakamura G. Konopaske M. Sidor C. D. Pernia N. Yamashita M. Wada Y. Inoue F. Nakamura S. D. Sheridan R. W. Logan M. Brandel D. Wu J. Hunsberger L. Dorsett C. Duerr R. C. B. Basa M. J. McCarthy N. D. Udeshi P. Mertins S. A. Carr G. A. Rouleau L. Mastrangelo J. Li G. J. Gutierrez L. M. Brill N. Venizelos G. Chen J. S. Nye H. Manji J. H. Price C. A. McClung H. S. Akiskal M. Alda D. M. Chuang J. T. Coyle Y. Liu Y. D. Teng T. Ohshima K. Mikoshiba R. L. Sidman S. Halpain S. J. Haggarty Y. Goshima E. Y. Snyder Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis Proc. Natl. Acad. Sci. U. S. A. 2017 114 E4462 E4471
242. J. Y. Lee J. H. Lee Y. W. Moon B. G. Chun J. W. Jahng Proteomic analysis of lithium-induced gene expression in the rat hypothalamus Int. J. Neurosci. 2009 119 1267 1281
243. D. Nanavati D. R. Austin L. A. Catapano D. A. Luckenbaugh A. Dosemeci H. K. Manji G. Chen S. P. Markey The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome J. Neurochem. 2011 119 617 629
244. T. W. Muhleisen M. Leber T. G. Schulze J. Strohmaier F. Degenhardt J. Treutlein M. Mattheisen A. J. Forstner J. Schumacher R. Breuer S. Meier S. Herms P. Hoffmann A. Lacour S. H. Witt A. Reif B. Muller-Myhsok S. Lucae W. Maier M. Schwarz H. Vedder J. Kammerer-Ciernioch A. Pfennig M. Bauer M. Hautzinger S. Moebus L. Priebe P. M. Czerski J. Hauser J. Lissowska N. Szeszenia-Dabrowska P. Brennan J. D. McKay A. Wright P. B. Mitchell J. M. Fullerton P. R. Schofield G. W. Montgomery S. E. Medland S. D. Gordon N. G. Martin V. Krasnow A. Chuchalin G. Babadjanova G. Pantelejeva L. I. Abramova A. S. Tiganov A. Polonikov E. Khusnutdinova M. Alda P. Grof G. A. Rouleau G. Turecki C. Laprise F. Rivas F. Mayoral M. Kogevinas M. Grigoroiu-Serbanescu P. Propping T. Becker M. Rietschel M. M. Nothen S. Cichon Genome-wide association study reveals two new risk loci for bipolar disorder Nat. Commun. 2014 5 3339
245. M. A. Ferreira M. C. O'Donovan Y. A. Meng I. R. Jones D. M. Ruderfer L. Jones J. Fan G. Kirov R. H. Perlis E. K. Green J. W. Smoller D. Grozeva J. Stone I. Nikolov K. Chambert M. L. Hamshere V. L. Nimgaonkar V. Moskvina M. E. Thase S. Caesar G. S. Sachs J. Franklin K. Gordon-Smith K. G. Ardlie S. B. Gabriel C. Fraser B. Blumenstiel M. Defelice G. Breen M. Gill D. W. Morris A. Elkin W. J. Muir K. A. McGhee R. Williamson D. J. MacIntyre A. W. MacLean C. D. St M. Robinson M. Van Beck A. C. Pereira R. Kandaswamy A. McQuillin D. A. Collier N. J. Bass A. H. Young J. Lawrence I. N. Ferrier A. Anjorin A. Farmer D. Curtis E. M. Scolnick P. McGuffin M. J. Daly A. P. Corvin P. A. Holmans D. H. Blackwood H. M. Gurling M. J. Owen S. M. Purcell P. Sklar N. Craddock C. Wellcome Trust Case Control Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder Nat. Genet. 2008 40 1056 1058
246. P. Corena-McLeod Mdel A. Oliveros C. Charlesworth B. Madden Y. Q. Liang M. Boules A. Shaw K. Williams E. Richelson Paliperidone as a mood stabilizer: a pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression Brain Res. 2008 1233 8 19
247. M. Corena-McLeod C. Walss-Bass A. Oliveros A. Gordillo Villegas C. Ceballos C. M. Charlesworth B. Madden P. J. Linser L. Van Ekeris K. Smith E. Richelson New model of action for mood stabilizers: phosphoproteome from rat pre-frontal cortex synaptoneurosomal preparations PLoS One 2013 8 e52147
248. B. K. Kishore C. M. Ecelbarger Lithium: a versatile tool for understanding renal physiology Am. J. Physiol.: Renal, Physiol. 2013 304 F1139 1149
249. J. Nielsen J. D. Hoffert M. A. Knepper P. Agre S. Nielsen R. A. Fenton Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: mechanisms for aquaporin 2 down-regulation and cellular proliferation Proc. Natl. Acad. Sci. U. S. A. 2008 105 3634 3639
250. A. Sussulini H. Dihazi C. E. Banzato M. A. Arruda W. Stuhmer H. Ehrenreich O. Jahn H. D. Kratzin Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder Proteomics 2011 11 261 269
251. 1H NMR spectroscopy and chemometrics Anal. Chem. 2009 81 9755 9763
252. B. Dean A. Digney S. Sundram E. Thomas E. Scarr Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder Psychiatry Res. 2008 158 75 78
253. G. N. Schrauzer Lithium: occurrence, dietary intakes, nutritional essentiality J. Am. Coll. Nutr. 2002 21 14 21
254. V. Tkatcheva D. Poirier R. Chong-Kit V. I. Furdui C. Burr R. Leger J. Parmar T. Switzer S. Maedler E. J. Reiner J. P. Sherry D. B. D. Simmons Lithium an emerging contaminant: bioavailability, effects on protein expression, and homeostasis disruption in short-term exposure of rainbow trout Aquat. Toxicol. 2015 161 85 93
255. J. M. Tognarelli M. Dawood M. I. Shariff V. P. Grover M. M. Crossey I. J. Cox S. D. Taylor-Robinson M. J. McPhail Magnetic Resonance Spectroscopy: Principles and Techniques: Lessons for Clinicians J. Clin. Exp. Hepatol. 2015 5 320 328
256. D. Bertholdo A. Watcharakorn M. Castillo Brain proton magnetic resonance spectroscopy: introduction and overview Neuroimaging Clinics North Am. 2013 23 359 380
257. M. Rango Parkinson's disease: in vivo brain metabolomics by MRS Int. Rev. Neurobiol. 2015 122 81 94
258. T. W. Fan P. Yuan A. N. Lane R. M. Higashi Y. Wang A. B. Hamidi R. Zhou X. Guitart G. Chen H. K. Manji R. Kaddurah-Daouk Stable isotope-resolved metabolomic analysis of lithium effects on glial-neuronal metabolism and interactions Metabolomics 2010 6 165 179
259. A. Yildiz-Yesiloglu D. P. Ankerst Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2006 30 969 995
260. I. C. Maurer P. Schippel H. P. Volz Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue Bipolar Disord. 2009 11 515 522
261. M. J. Lan G. A. McLoughlin J. L. Griffin T. M. Tsang J. T. Huang P. Yuan H. Manji E. Holmes S. Bahn Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder Mol. Psychiatry 2009 14 269 279
262. B. Perroud P. Jafar-Nejad W. R. Wikoff J. R. Gatchel L. Wang D. K. Barupal J. Crespo-Barreto O. Fiehn H. Y. Zoghbi R. Kaddurah-Daouk Pharmacometabolomic signature of ataxia SCA1 mouse model and lithium effects PLoS One 2013 8 e70610
263. K. J. Burghardt S. J. Evans K. M. Wiese V. L. Ellingrod An Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar Disorder Clin. Transl. Sci. 2015 8 432 440
264. A. Villasenor A. Ramamoorthy M. Silva dos Santos M. P. Lorenzo G. Laje C. Zarate, Jr. C. Barbas I. W. Wainer A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks Br. J. Pharmacol. 2014 171 2230 2242
265. N. Yoshimi T. Futamura K. Kakumoto A. M. Salehi C. M. Sellgren J. Holmen-Larsson J. Jakobsson E. Palsson M. Landen K. Hashimoto Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder BBA Clin. 2016 5 151 158
266. I. Lee Betaine is a positive regulator of mitochondrial respiration Biochem. Biophys. Res. Commun. 2015 456 621 625
267. J. Ye J. Fan S. Venneti Y. W. Wan B. R. Pawel J. Zhang L. W. Finley C. Lu T. Lindsten J. R. Cross G. Qing Z. Liu M. C. Simon J. D. Rabinowitz C. B. Thompson Serine catabolism regulates mitochondrial redox control during hypoxia Cancer Discovery 2014 4 1406 1417
268. J. Y. Hsieh J. H. Liu P. C. Yang C. L. Lin G. Y. Liu H. C. Hung Fumarate analogs act as allosteric inhibitors of the human mitochondrial NAD(P)+-dependent malic enzyme PLoS One 2014 9 e98385
269. G. E. Gibson J. P. Blass M. F. Beal V. Bunik The alpha-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration Mol. Neurobiol. 2005 31 43 63
270. J. B. Clark N -Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial Dysfunction Dev. Neurosci. 1998 20 271 276
271. G. S. Hwang J. Y. Yang D. H. Ryu T. H. Kwon Metabolic profiling of kidney and urine in rats with lithium-induced nephrogenic diabetes insipidus by (1)H-NMR-based metabonomics Am. J. Physiol.: Renal, Physiol. 2010 298 F461 470
272. M. B. Burg J. D. Ferraris Intracellular organic osmolytes: function and regulation J. Biol. Chem. 2008 283 7309 7313
273. P. H. Yancey M. E. Clark S. C. Hand R. D. Bowlus G. N. Somero Living with water stress: evolution of osmolyte systems Science 1982 217 1214 1222
274. S. Rej M. Segal N. C. Low I. Mucsi C. Holcroft K. Shulman K. J. Looper In this correspondence, preliminary data in 100 lithium users found that urine osmolality correlated with chronic kidney disease, diabetes mellitus, and hypothyroidism. We hypothesize that GSK-3beta inhibition is a potential mechanism for lithium-associated medical illness Med. Hypotheses 2015 84 602
275. C. L. Chien Y. S. Wu H. L. Lai Y. H. Chen S. T. Jiang C. M. Shih S. S. Lin C. Chang Y. Chern Impaired water reabsorption in mice deficient in the type VI adenylyl cyclase (AC6) FEBS Lett. 2010 584 2883 2890
276. R. Rao S. Patel C. Hao J. Woodgett R. Harris GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity J. Am. Soc. Nephrol. 2010 21 428 437
277. E. G. Nagato J. C. D'Eon B. P. Lankadurai D. G. Poirier E. J. Reiner A. J. Simpson M. J. Simpson (1)H NMR-based metabolomics investigation of Daphnia magna responses to sub-lethal exposure to arsenic, copper and lithium Chemosphere 2013 93 331 337
278. F. Bosetti J. Rintala R. Seemann T. A. Rosenberger M. A. Contreras S. I. Rapoport M. C. Chang Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain Mol. Psychiatry 2002 7 845 850
279. S. I. Rapoport F. Bosetti Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Arch. Gen. Psychiatry 2002 59 592 596
280. S. I. Rapoport Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade ACS Chem. Neurosci. 2014 5 459 467
281. S. E. Kim I. B. Lee C. Hyeon S. C. Hong Destabilization of i-motif by submolar concentrations of a monovalent cation J. Phys. Chem. B 2014 118 4753 4760
282. F. Wang X. Liu I. Willner DNA switches: from principles to applications Angew. Chem., Int. Ed. 2015 54 1098 1129
283. L. Hou U. Heilbronner F. Degenhardt M. Adli K. Akiyama N. Akula R. Ardau B. Arias L. Backlund C. E. Banzato A. Benabarre S. Bengesser A. K. Bhattacharjee J. M. Biernacka A. Birner C. Brichant-Petitjean E. T. Bui P. Cervantes G. B. Chen H. C. Chen C. Chillotti S. Cichon S. R. Clark F. Colom D. A. Cousins C. Cruceanu P. M. Czerski C. R. Dantas A. Dayer B. Etain P. Falkai A. J. Forstner L. Frisen J. M. Fullerton S. Gard J. S. Garnham F. S. Goes P. Grof O. Gruber R. Hashimoto J. Hauser S. Herms P. Hoffmann A. Hofmann S. Jamain E. Jimenez J. P. Kahn L. Kassem S. Kittel-Schneider S. Kliwicki B. Konig I. Kusumi N. Lackner G. Laje M. Landen C. Lavebratt M. Leboyer S. G. Leckband C. A. Jaramillo G. MacQueen M. Manchia L. Martinsson M. Mattheisen M. J. McCarthy S. L. McElroy M. Mitjans F. M. Mondimore P. Monteleone C. M. Nievergelt M. M. Nothen U. Osby N. Ozaki R. H. Perlis A. Pfennig D. Reich-Erkelenz G. A. Rouleau P. R. Schofield K. O. Schubert B. W. Schweizer F. Seemuller G. Severino T. Shekhtman P. D. Shilling K. Shimoda C. Simhandl C. M. Slaney J. W. Smoller A. Squassina T. Stamm P. Stopkova S. K. Tighe A. Tortorella G. Turecki J. Volkert S. Witt A. Wright L. T. Young P. P. Zandi J. B. Potash J. R. DePaulo M. Bauer E. Z. Reininghaus T. Novak J. M. Aubry M. Maj B. T. Baune P. B. Mitchell E. Vieta M. A. Frye J. K. Rybakowski P. H. Kuo T. Kato M. Grigoroiu-Serbanescu A. Reif M. Del Zompo F. Bellivier M. Schalling N. R. Wray J. R. Kelsoe M. Alda M. Rietschel F. J. McMahon T. G. Schulze Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study Lancet 2016 387 1085 1093
284. L. Lowthert J. Leffert A. Lin S. Umlauf K. Maloney A. Muralidharan B. Lorberg S. Mane H. Zhao R. Sinha Z. Bhagwagar R. Beech Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation Biol. Mood Anxiety Disord. 2012 2 15